AR-401

N/A

Report date: 2024/07/04 20:00:24

Base Information

Drug NameAR-401
Drug Alias NameAR-401KBAB-401
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionImmunomodulators
TargetsUpdating
Therapy Area/IndicationsHealthcare-Associated PneumoniaAcinetobacter Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKenta Biotech
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKenta BiotechAridis Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsHealthcare-Associated PneumoniaAcinetobacter Infections

Other Information

ATC CodeN/A
Related LinksN/A